- Summits
- Sponsorship
- News
- About
Around 200 MedTech enthusiasts from the U.S., Europe, and the rest of the world gathered on 13 March in the heart of the Texas Medical Center for MedTech Houston Rodeo 2025. The event brought together a close-knit community of innovators, investors, and industry leaders, fostering discussions on the latest MedTech advancements and collaboration opportunities across borders. The day was filled with knowledge-sharing and networking and concluded in true Texas fashion—with live music, food, beverages, and a BBQ networking session.
MedTech Houston Rodeo marks MedTech World’s first U.S. event of the year, with more events to be announced soon.
Presented by Lifeblood, supported by MedTech World and Goodwin Procter, and sponsored by Ascend Clinical, VitaTek, Nunex, Saint Arnold, and Stream Retail, the event also featured a Texas wine presentation and tasting by collaborator Threshold Vineyards.
The day kicked off with a fireside chat featuring Jonathan Norris, Manager Healthcare Venture Relationships at HSBC’s Innovation Banking Division; Martin Gomez, Partner at Goodwin Procter LLP; and Giovanni Lauricella, CEO at Lifeblood, setting the stage for a series of dynamic panel discussions that explored key themes in MedTech innovation, investment, and acquisition. Among the standout sessions were:
A deep dive into the recent acquisition of Galen Data, featuring insights from Alex Condon, COO of Galen Data; Giovanni Lauricella, CEO of Lifeblood; Abbas Dhilawala, CTO of Galen Data; and Chris DuPont, CEO of Galen Data. The panel explored the journey leading to the acquisition and its impact on the MedTech sector.
From left to right: Chris DuPont, CEO of Galen Data and Alex Condon, COO of Galen Data, during the panel Houston’s Newest Success Story: The Galen Data Acquisition
A critical discussion on MedTech acquisitions, providing expert perspectives on successful exits, investment strategies, and the nuances of deal-making. Speakers included Chris Mathia, Founder at 2409 Advisors; Thomas Busby, Director, Investment Banking at Outcome Capital; David Kereiakes, Managing Partner at Windham Capital Partners; and Dave McDonough, President at NTI-Northgate Technologies.
A thought-provoking session moderated by Savannah Esteve Morreale, Program Director, Surgery Innovation at MD Anderson Cancer Center, explored how academic research can fuel MedTech innovation, attract investment, and drive commercialization. Panelists included Cristina Checka, Associate Professor, Department of Breast Surgical Oncology, MD Anderson Cancer Center; Rishindra Reddy, Professor of Thoracic Surgery, Center for Surgical Innovation, Director, University of Michigan; and Candice Stegink, Associate Director of Innovation in the MM, Surgery Department, University of Michigan. Together, they discussed the intersection of research, innovation, and industry impact.
In her closing remarks, Yulia Yurevich, Head of Client Relations and Partnerships at MedTech World, reinforced MedTech World’s commitment to fostering global connections:
“MedTech World has established a strong foothold in Europe and the Middle East, is rapidly expanding in Asia, and is now making a bold entry into the U.S. market. While the U.S. is often the ultimate destination for MedTech startups, true success here depends on a strong global foundation. Innovation thrives when ecosystems connect, and that’s exactly what we’re doing: building stronger bridges between markets like Malta and Texas to accelerate MedTech growth worldwide. As we expand in the U.S., we’re not just joining the market but actively shaping its future by fostering these critical global connections. And of course, I want to extend a special thank you to Giovanni for being instrumental in making this happen.”
As MedTech World solidifies its presence in the U.S., the search for a permanent host city is underway. The ideal location will be one with a thriving healthcare and MedTech ecosystem, where startups, investors, and industry leaders can converge to drive innovation. The U.S. remains the global leader in MedTech, boasting top-tier research institutions, a strong regulatory framework, and unparalleled access to capital.
To ensure a successful entry into the U.S. market, MedTech World is looking at key factors such as:
Dr. Dylan Attard, CEO and Cofounder of MedTech World, said, “The United States has long been the epicenter of medical technology, with an industry that continues to set the global standard for innovation. The country is home to some of the biggest names in MedTech, from established giants to rising startups reshaping healthcare. With a regulatory landscape that supports commercialization, a dynamic investment ecosystem, and a culture of technological advancement, the U.S. provides the perfect foundation for MedTech World’s continued growth. By establishing a foothold in the U.S., MedTech World aims to bridge international markets, offering startups and investors access to new opportunities while maintaining its commitment to fostering a global MedTech ecosystem.”
This commitment was already evident at MedTech Malta 2024, where two panels were dedicated to Houston, showcasing the city’s impact on the global MedTech ecosystem. The dialogue initiated there was further strengthened today in Houston, proving the growing synergy between these two hubs of innovation.
Houston has emerged as a focal point in MedTech World’s expansion strategy, bridging the European and American MedTech ecosystems. With the Texas Medical Center serving as a global hub for healthcare innovation, the city offers excellent resources for startups, investors, and researchers. The conversations at MedTech Houston 2025 reinforced the city’s role in driving forward medical advancements and fostering collaborations that extend beyond borders.
MedTech World’s journey keeps gaining momentum, leading to our flagship event, MedTech Malta 2025, on November 12-14! Don’t miss this opportunity to connect with industry leaders, investors, and innovators in MedTech. Book your tickets now or contact us at [email protected] for collaborative opportunities.
